用分子理性基础进行化疗,托西菲林作为有前途的抗瘤药物
Cesar R Cerda-Cruz1, Jorge R Vazquez-Urrutia1, Pablo C Ortiz-Lazareno1
1Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.
Annals of medicine and surgery (2012)
|April 11, 2025
概括
托西菲林 (PTX) 通过向瘤细胞,在癌症治疗中表现有前途,可能改善化疗结果. 需要进一步的临床试验来确认其在患者中的益处和安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 癌症仍然是全球主要的死亡原因,目前的化疗等疗法由于对健康细胞的损害而导致显著的副作用.
- 开发新的抗癌药物是一个昂贵和耗时的过程.
- 基于分子理性基础的化疗旨在识别特定的瘤细胞点,以诱导亡或增强对治疗的敏感性.
研究的目的:
- 审查现有的实验和临床证据,以pentoxifylline (PTX) 作为癌症治疗中的重用药物.
- 以分子理性基础评估PTX在化疗中的作用.
- 评估PTX作为一种可访问和安全的抗癌剂的潜力.
主要方法:
- 对2003年1月至2024年10月期间发表的研究进行了文献搜索.
- 包括的文章是英语或西班牙语的.
- 使用的关键词是"pentoxifylline"或"BL 191"或"trental"和"癌症"用于体外,体内和临床研究.
主要成果:
- 托西菲林 (PTX) 是一种已批准的,可获得的,相对安全的药物.
- 实质性的实验和临床证据表明,PTX在癌症治疗中具有有益作用.
- 单独或组合使用PTX的疗效与传统化疗方案相美,甚至超过了它们.
结论:
- 托西菲林 (PTX) 在癌症治疗中显示出药物重新定位的巨大潜力.
- 更大的临床试验对于充分了解PTX的益处,不良反应和与当前化疗的相互作用至关重要.
- 进一步的研究可以将PTX作为癌症治疗策略的宝贵补充,改善患者的治疗结果.
更多相关视频
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
2.9K
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.0K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Tumor Immunotherapy
411
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
411
Electron Transport Chain: Complex I and II
9.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
9.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
